BAP1 and neoplasm: BRCA1-associated protein 1 (BAP1) deficiency, primarily caused by its expression losses and mutations, triggers molecular mechanisms that drive tumour growth and impact UM outcome, making it a powerful prognostic biomarker [88–93].